Liu, Bo
Abdel-Wahab, Omar http://orcid.org/0000-0002-3907-6171
Article History
First Online: 27 July 2020
Competing interests
: O.A.-W. has served as a consultant for H3B Biomedicine, Foundation Medicine Inc, Merck, and Janssen, and is on the Scientific Advisory Board of Envisagenics Inc and AIChemy; O.A.-W. has received prior research funding from H3B Biomedicine unrelated to the current manuscript.